Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, suppress glucagon https://kianaxcmw548858.wikimidpoint.com/6507085/glp_1_receptor_agonists_retaglutide_and_tirzepatide